1985Journal of Ocular Pharmacology and TherapeuticsRequires access

Pilocarpine Mydriasis in Mice

Р.П. Коваль, Amos D. Korczyn

Open publisher page 2 citations

Abstract

In several rodent species pilocarpine and oxotremorine produce mydriasis, rather than the miosis which is characteristic of most other species. We have established that pilocarpine is a mydriatic drug in mice, a species in which the action has previously not been described, and that this effect occurs after local ocular, intraperitoneal (IP) or intracerebroventricular (ICV) application. Arecoline produces miosis or mydriasis (depending on dose) following direct ocular application but mild mydriasis after IP or ICV injection. Atropine also produces mydriasis in mice, and the effect of pilocarpine is additive with that produced by atropine and is not antagonized by antihistamines. Direct ICV pilocarpine injection produces mydriasis at doses equivalent to those used systemically. Pilocarpine mydriasis probably results from inhibition of parasympathetic activity.

About this research paper

What this paper is about

In several rodent species pilocarpine and oxotremorine produce mydriasis, rather than the miosis which is characteristic of most other species. We have established that pilocarpine is a mydriatic drug in mice, a species in which the action has previously not been described, and that this effect occurs after local ocular, intraperitoneal (IP) or intracerebroventricular (ICV) application. Arecoline produces miosis or mydriasis (depending on dose) following direct ocular application but mild mydriasis after IP or ICV injection. Atropine also produces mydriasis in mice, and the effect of pilocarpine is additive with that produced by atropine and is not antagonized by antihistamines. Direct ICV pilocarpine injection produces mydriasis at doses equivalent to those used systemically. Pilocarpine mydriasis probably results from inhibition of parasympathetic activity.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In several rodent species pilocarpine and oxotremorine produce mydriasis, rather than the miosis which is characteristic of most other species. We have established that pilocarpine is a mydriatic drug in mice, a species in which the action has previously not been described, and that this effect occurs after local ocular, intraperitoneal (IP) or intracerebroventricular (ICV) application. Arecoline produces miosis or mydriasis (depending on dose) following direct ocular application but mild mydriasis after IP or ICV injection. Atropine also produces mydriasis in mice, and the effect of pilocarpine is additive with that produced by atropine and is not antagonized by antihistamines. Direct ICV pilocarpine injection produces mydriasis at doses equivalent to those used systemically. Pilocarpine mydriasis probably results from inhibition of parasympathetic activity.

Key concepts: Mydriasis, Pilocarpine, Miosis, Atropine, Pharmacology, Intraperitoneal injection, Anesthesia, Parasympatholytic

Related papers

Back to paper searchBrowse research topicsOriginal source
Pilocarpine Mydriasis in Mice — Research Paper | ScholarLens